These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2471792)

  • 21. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.
    Schmaljohn CS; Chu YK; Schmaljohn AL; Dalrymple JM
    J Virol; 1990 Jul; 64(7):3162-70. PubMed ID: 1972201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of ELISA on the basis of monoclonal antibodies for detecting specific activity of the vaccine against hemorrhagic fever with renal syndrome].
    Dzagurova TK; Solopova ON; Sveshnikov PG; Korotina NA; Balovneva MV; Leonovich OA; Varlamov NE; Malkin GA; Sotskova SE; Tkachenko EA
    Vopr Virusol; 2013; 58(1):40-4. PubMed ID: 23785761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
    Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of neutralizing monoclonal antibody escape mutants of Hantaan virus 76118.
    Kikuchi M; Yoshimatsu K; Arikawa J; Yoshida R; Yoo YC; Isegawa Y; Yamanishi K; Tono-oka S; Azuma I
    Arch Virol; 1998; 143(1):73-83. PubMed ID: 9505967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic relationships of hantavirus strains analysed by monoclonal antibodies.
    Dzagurova T; Tkachenko E; Slonova R; Ivanov L; Ivanidze E; Markeshin S; Dekonenko A; Niklasson B; Lundkvist A
    Arch Virol; 1995; 140(10):1763-73. PubMed ID: 7503677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
    Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus.
    Wang M; Pennock DG; Spik KW; Schmaljohn CS
    Virology; 1993 Dec; 197(2):757-66. PubMed ID: 7504368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and functional characterization of rinderpest virus envelope proteins using monoclonal antibodies.
    Sugiyama M; Minamoto N; Kinjo T; Hirayama N; Asano K; Tsukiyama-Kohara K; Yoshikawa Y; Yamanouchi K
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1863-9. PubMed ID: 1714940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies.
    Luo TR; Minamoto N; Hishida M; Yamamoto K; Fujise T; Hiraga S; Ito N; Sugiyama M; Kinjo T
    Microbiol Immunol; 1998; 42(3):187-93. PubMed ID: 9570284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein.
    Hawkes RA; Roehrig JT; Hunt AR; Moore GA
    J Gen Virol; 1988 May; 69 ( Pt 5)():1105-9. PubMed ID: 2453607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of neutralizing monoclonal antibodies on Hantaan virus infection of the macrophage P388D1 cell line.
    Yao JS; Arikawa J; Kariwa H; Yoshimatsu K; Takashima I; Hashimoto N
    Jpn J Vet Res; 1992 Sep; 40(2-3):87-97. PubMed ID: 1284283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.
    Walsh EE; Hall CB; Schlesinger JJ; Brandriss MW; Hildreth S; Paradiso P
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2953-61. PubMed ID: 2479715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes.
    Pereboev AV; Razumov IA; Svyatchenko VA; Loktev VB
    Arch Virol; 1996; 141(11):2191-205. PubMed ID: 8973533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.
    Ruo SL; Sanchez A; Elliott LH; Brammer LS; McCormick JB; Fisher-Hoch SP
    Arch Virol; 1991; 119(1-2):1-11. PubMed ID: 1907448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topographical rearrangements of visna virus envelope glycoprotein during antigenic drift.
    Stanley J; Bhaduri LM; Narayan O; Clements JE
    J Virol; 1987 Apr; 61(4):1019-28. PubMed ID: 2434662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.